Begin main content

Call for Patient Input and Clinical Experts: Translarna

Published on: March 5, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s). 

Brand name Translarna
Generic name ataluren
Manufacturer PTC Therapeutics Canada ULC
Indication(s) Dystrophinopathy
Project Number SR0607-000
Call for patient input 2019-03-05
Patient input deadline 2019-04-24
Submit patient input Submit
Register as Clinical Expert Register